Industry News
Fixing Common Blood Disorder Would Make Kidney Transplants More Successful
Dec 27, 2011
Correcting anemia, a red blood cell deficiency, can preserve kidney function in many kidney transplant recipients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results indicate that aggressively treating anemia may help save the kidneys and possibly the lives of many transplant recipients... Read More
Restricting Post-Surgery Blood Transfusion Is Safe For Some Hip Patients
Dec 27, 2011
More than half of the older, anemic patients in a New England Journal of Medicine study did not need blood transfusions as they recovered from hip surgery, according to new research co-authored by University of Maryland School of Medicine scientists. The findings could immediately change the way such patients are treated... Read More
Angina Medication May Be Effective For Managing Certain Cancers, Study Finds
Dec 26, 2011
Researchers at Queen's University have identified a new mechanism that could potentially explain why the body's immune system sometimes fails to eliminate cancer... Read More
Thousands Of Lives Could Be Saved By Simple Test To Help Diagnose Bowel And Pancreatic Cancer
Dec 26, 2011
A simple online calculator could offer family GPs a powerful new tool in tackling two of the most deadly forms of cancer, say researchers... Read More
Bevacizumab Reduces Nasopharyngeal Carcinoma Spread - Trial Finds
Dec 26, 2011
According to a new phase 2 trial published Online First in The Lancet Oncology, the combination of the widely used anti-cancer drug bevacizumab with standard chemo-radiation therapy is safe, and could prolong survival in patients with advanced nasopharyngeal carcinoma, without any apparent increased adverse side effects... Read More
KS-Herpesvirus Induces Reprogramming Of Lymphatic Endothelial Cells To Invasive Mesenchymal Cells
Dec 26, 2011
Human tumor viruses contribute to 15-20% of human cancers worldwide. Kaposi's sarcoma herpesvirus (KSHV) is an etiological agent for Kaposi's sarcoma (KS) and two other rare lymphoproliferative malignancies. KS is the most common cancer in HIV-infected untreated individuals and remains a primary cause of cancer deaths in many subequatorial African countries as a result of the AIDS pandemic... Read More
Improving Cancer Care Via Patient Empowerment And System Transformation
Dec 26, 2011
Physicians can use medical records to track the quality of cancer care and determine whether their patients are receiving the right treatments at the right time. Yet the patient is the only one who ultimately can evaluate the quality of his or her experience while receiving treatment... Read More
Roche's Avastin Receives EU Approval For Ovarian Cancer
Dec 25, 2011
Roche announced today that its product known as Avastin (bevacizumab) has been approved by the European Union for treatment of ovarian cancer. When used in combination with standard chemotherapy (carboplatin and paclitaxel) it will be part of a front-line (first-line following surgery) regime. Hal Barron M.D... Read More
Acid Reflux 50% More Common Than Ten Years Ago
Dec 25, 2011
A long-term Norwegian study reveals the number of people who experience acid reflux at least once a week has gone up by nearly 50% in the last 10 years, with women appearing to be more susceptible to the condition than men... Read More
Visualization Of DNA Synthesis In Vivo
Dec 25, 2011
Interactions of biological macromolecules are the central bases of living systems. Biological macromolecules are synthesized in living cells by linking many small molecules together. Naturally occurring macromolecules include genetic materials (DNA) and proteins... Read More
Previous Page Next Page
